Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Little

Showing results (1181-1190 of 1,276) with videos related to

Pageof 128
Sort By:
Bioorganic & Medicinal Chemistry Letters|March 4, 2008
Novel trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidines as mu opioid receptor antagonists with improved opioid receptor selectivity profilesBertrand Le Bourdonnec, William M Barker, Serge Belanger, et al.
Journal of Virology|February 5, 2016
Replication of Human Herpesviruses Is Associated with Higher HIV DNA Levels during Antiretroviral Therapy Started at Early Phases of HIV InfectionSara Gianella, Christy M Anderson, Susanna R Var, et al.
Journal of Virology|May 3, 2014
Cytomegalovirus replication in semen is associated with higher levels of proviral HIV DNA and CD4+ T cell activation during antiretroviral treatmentSara Gianella, Marta Massanella, Douglas D Richman, et al.
Ebiomedicine|December 3, 2015
HIV Transmission Networks in the San Diego-Tijuana Border RegionSanjay R Mehta, Joel O Wertheim, Kimberly C Brouwer, et al.
Bioorganic & Medicinal Chemistry Letters|April 24, 2008
Sulfamoyl benzamides as novel CB2 cannabinoid receptor ligandsKarin Worm, Q Jean Zhou, Christopher T Saeui, et al.
AIDS (London, England)|October 21, 2006
Greater CD4 T-cell gains after one year of antiretroviral therapy are associated with lower HIV-1 pol replication capacityJason D Barbour, Frederick M Hecht, Susan J Little, et al.
Neurology|September 2, 2009
Resting cerebral blood flow: a potential biomarker of the effects of HIV in the brainB M Ances, D Sisti, F Vaida, et al.
The Journal of Infectious Diseases|April 6, 2005
Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1Matthew C Strain, Susan J Little, Eric S Daar, et al.
AIDS (London, England)|March 25, 2024
Impact of influenza and pneumococcal vaccines on HIV persistence and immune dynamics during suppressive antiretroviral therapySara Gianella, Christy Anderson, Antoine Chaillon, et al.
Science Bulletin|April 17, 2026
Hepatic IFRD1 suppresses metabolic dysfunction-associated fatty liver disease via GLUD1/α-KG axisMengya Geng, Fanzheng Meng, Hairui Li, et al.
Pageof 128

Showing results (1181-1190 of 1,276) with videos related to

Sort By:
Pageof 128
Bioorganic & Medicinal Chemistry Letters|March 4, 2008
Novel trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidines as mu opioid receptor antagonists with improved opioid receptor selectivity profilesBertrand Le Bourdonnec, William M Barker, Serge Belanger, et al.
Journal of Virology|February 5, 2016
Replication of Human Herpesviruses Is Associated with Higher HIV DNA Levels during Antiretroviral Therapy Started at Early Phases of HIV InfectionSara Gianella, Christy M Anderson, Susanna R Var, et al.
Journal of Virology|May 3, 2014
Cytomegalovirus replication in semen is associated with higher levels of proviral HIV DNA and CD4+ T cell activation during antiretroviral treatmentSara Gianella, Marta Massanella, Douglas D Richman, et al.
Ebiomedicine|December 3, 2015
HIV Transmission Networks in the San Diego-Tijuana Border RegionSanjay R Mehta, Joel O Wertheim, Kimberly C Brouwer, et al.
Bioorganic & Medicinal Chemistry Letters|April 24, 2008
Sulfamoyl benzamides as novel CB2 cannabinoid receptor ligandsKarin Worm, Q Jean Zhou, Christopher T Saeui, et al.
AIDS (London, England)|October 21, 2006
Greater CD4 T-cell gains after one year of antiretroviral therapy are associated with lower HIV-1 pol replication capacityJason D Barbour, Frederick M Hecht, Susan J Little, et al.
Neurology|September 2, 2009
Resting cerebral blood flow: a potential biomarker of the effects of HIV in the brainB M Ances, D Sisti, F Vaida, et al.
The Journal of Infectious Diseases|April 6, 2005
Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1Matthew C Strain, Susan J Little, Eric S Daar, et al.
AIDS (London, England)|March 25, 2024
Impact of influenza and pneumococcal vaccines on HIV persistence and immune dynamics during suppressive antiretroviral therapySara Gianella, Christy Anderson, Antoine Chaillon, et al.
Science Bulletin|April 17, 2026
Hepatic IFRD1 suppresses metabolic dysfunction-associated fatty liver disease via GLUD1/α-KG axisMengya Geng, Fanzheng Meng, Hairui Li, et al.
Pageof 128